Bioleaders Corporation (142760) — Working Capital to Net Assets Ratio
Bioleaders Corporation (142760) has a Working Capital to Net Assets ratio of 34.1% as of June 2026. Working capital of ₩8.24 Billion (current assets of ₩15.95 Billion minus current liabilities of ₩7.72 Billion) is measured against net assets of ₩24.19 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See defensive interval ratio of Bioleaders Corporation to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Bioleaders Corporation Working Capital to Net Assets (2015–2025)
This chart shows how Bioleaders Corporation's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of June 2026, the ratio stands at 34.1%, reflecting working capital of ₩8.24 Billion against net assets of ₩24.19 Billion KRW. For the complete balance sheet picture, see 142760 asset base.
Annual Working Capital to Net Assets for Bioleaders Corporation (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Bioleaders Corporation from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check how resilient are Bioleaders Corporation's assets to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 49.3% | ₩15.06 Billion | ₩30.57 Billion | ₩26.52 Billion | ₩11.46 Billion | ▼ -19.7 pp |
| 2024 | 69.0% | ₩25.74 Billion | ₩37.31 Billion | ₩46.37 Billion | ₩20.63 Billion | ▲ +20.6 pp |
| 2023 | 48.4% | ₩17.31 Billion | ₩35.79 Billion | ₩29.84 Billion | ₩12.53 Billion | ▲ +17.0 pp |
| 2022 | 31.4% | ₩6.80 Billion | ₩21.69 Billion | ₩71.77 Billion | ₩64.97 Billion | ▼ -80.4 pp |
| 2021 | 111.8% | ₩50.44 Billion | ₩45.11 Billion | ₩97.14 Billion | ₩46.70 Billion | ▲ +78.3 pp |
| 2020 | 33.5% | ₩10.26 Billion | ₩30.60 Billion | ₩73.53 Billion | ₩63.26 Billion | ▲ +17.9 pp |
| 2019 | 15.7% | ₩3.73 Billion | ₩23.82 Billion | ₩66.55 Billion | ₩62.82 Billion | ▲ +52.0 pp |
| 2018 | -36.3% | ₩-8.54 Billion | ₩23.50 Billion | ₩69.23 Billion | ₩77.77 Billion | ▼ -118.7 pp |
| 2017 | 82.4% | ₩28.96 Billion | ₩35.17 Billion | ₩30.91 Billion | ₩1.94 Billion | ▼ -0.5 pp |
| 2016 | 82.9% | ₩14.47 Billion | ₩17.46 Billion | ₩17.67 Billion | ₩3.20 Billion | ▲ +2.8 pp |
| 2015 | 80.1% | ₩4.45 Billion | ₩5.55 Billion | ₩7.90 Billion | ₩3.45 Billion | — |